Timentin and Rash maculo-papular - a phase IV clinical study of FDA data

Summary:

Rash maculo-papular is reported as a side effect among people who take Timentin (clavulanate potassium; ticarcillin disodium), especially for people who are female, 60+ old, also take Acetaminophen, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Rash maculo-papular when taking Timentin. It is created by eHealthMe based on reports of 619 people who have side effects when taking Timentin from the FDA, and is updated regularly.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,243 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

619 people reported to have side effects when taking Timentin.
Among them, 12 people (1.94%) have Rash maculo-papular.

Could Timentin cause Rash maculo-papular?

Among these 12 people:

What is the gender of people who have Rash maculo-papular when taking Timentin? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Rash maculo-papular when taking Timentin? *

What are other drugs people take besides Timentin? *

What are other side effects people have besides Rash maculo-papular? *

Cough: 9 people, 75.00%
Atelectasis (partial or complete collapse of the lung): 9 people, 75.00%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 9 people, 75.00%
Chest Pain: 9 people, 75.00%
Pericardial Effusion (fluid around the heart): 9 people, 75.00%
Weakness: 8 people, 66.67%
Anaemia (lack of blood): 8 people, 66.67%
Diarrhea: 8 people, 66.67%
Dyspnea (difficult or laboured breathing): 8 people, 66.67%
Cardiac Disorder: 8 people, 66.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 58.33%
Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Timentin and have Rash maculo-papular?

- Check whether Rash maculo-papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timentin:

Timentin (624 reports)

Rash maculo-papular treatments and more:

Rash maculo-papular (27,124 reports)

How severe was Rash maculo-papular and when was it recovered:

Rash maculo-papular in Timentin

Expand to all the drugs that have ingredients of clavulanate potassium; ticarcillin disodium:

Rash maculo-papular and drugs with ingredients of clavulanate potassium; ticarcillin disodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash maculo-papular:

Rash maculo-papular (1,243 drugs)

Browse all the conditions that are associated with Rash maculo-papular:

Rash maculo-papular (1,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clavulanate potassium; ticarcillin disodium (the active ingredients of Timentin) and Timentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.